Cargando…

Levodopa-Induced Dyskinesia in Parkinson's Disease

This book aims to provide a single reference source on levodopa-induced dyskinesias (LID) from 'bench to bedside'. Initial chapters review the clinical features and phenomenology of LID with video examples; epidemiology and genetic risk factors for LID are covered as a background to unders...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Fox, Susan H. (Editor ), Brotchie, Jonathan M. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London : Springer London : Imprint: Springer, 2014.
Edición:1st ed. 2014.
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-1-4471-6503-3
003 DE-He213
005 20220121010303.0
007 cr nn 008mamaa
008 141008s2014 xxk| s |||| 0|eng d
020 |a 9781447165033  |9 978-1-4471-6503-3 
024 7 |a 10.1007/978-1-4471-6503-3  |2 doi 
050 4 |a RC346-429.2 
072 7 |a MJN  |2 bicssc 
072 7 |a MED056000  |2 bisacsh 
072 7 |a MKJ  |2 thema 
082 0 4 |a 616.8  |2 23 
245 1 0 |a Levodopa-Induced Dyskinesia in Parkinson's Disease  |h [electronic resource] /  |c edited by Susan H. Fox, Jonathan M. Brotchie. 
250 |a 1st ed. 2014. 
264 1 |a London :  |b Springer London :  |b Imprint: Springer,  |c 2014. 
300 |a XII, 368 p. 12 illus., 11 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Phenomenology of Levodopa-Induced Dyskinesia -- Dyskinesia Rating Scales in Parkinson's Disease -- Epidemiology of Levodopa-Induced Dyskinesia -- Risk Factors for Levodopa-Induced Dyskinesia -- Pharmacological Treatment Options for Levodopa-Induced Dyskinesia -- Surgical Options for Levodopa-Induced Dyskinesia in Parkinson's Disease -- Basal Ganglia Circuitry Models of L-DOPA-Induced Dyskinesia -- Basal Ganglia Circuitry Models of L-DOPA-Induced Dyskinesia -- Pharmacological Properties of Levodopa -- Dopamine Receptors and LID -- The Serotonergic System In Levodopa-Induced Dyskinesia -- The Opioid System in Levodopa-Induced Dyskinesia -- Glutamate Receptors and Levodopa-Induced Dyskinesia -- Cannabinoids and Levodopa-Induced Dyskinesia -- The Role of the Noradrenergic System and its Receptors In Levodopa-Induced Dyskinesia -- Involvement of the Cholinergic System in Levodopa-Induced Dyskinesia -- New Clinical Trials for Levodopa-Induced Dyskinesia -- Preclinical Models of Levodopa-Induced Dyskinesia -- Final Thoughts: Summary and Future Therapeutic Strategies in LID. 
520 |a This book aims to provide a single reference source on levodopa-induced dyskinesias (LID) from 'bench to bedside'. Initial chapters review the clinical features and phenomenology of LID with video examples; epidemiology and genetic risk factors for LID are covered as a background to understanding risk factors for developing LID. The following chapters cover the latest preclinical studies aiming to understand the pathophysiology of LID at the cellular, neurochemical, neurophysiological and circuitry level with detailed discussion of mechanisms and future directions to take the field forward; clinical studies from phase II to phase IV; ongoing RCTs in LID; and evidence-based medicine reviews of treatment options.  Levodopa-Induced Dyskinesia in Parkinson's Disease is aimed at an international audience of movement disorder neurologists; neuroscientists; trainees; and graduate and post-graduate students. 
650 0 |a Neurology . 
650 0 |a Neurosciences. 
650 1 4 |a Neurology. 
650 2 4 |a Neuroscience. 
700 1 |a Fox, Susan H.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Brotchie, Jonathan M.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9781447165040 
776 0 8 |i Printed edition:  |z 9781447165026 
776 0 8 |i Printed edition:  |z 9781447172383 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-1-4471-6503-3  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)